Methods of using adipose derived regenerative cells to promote restoration of intevertebral disc
View Patent ↗Regenerative cells present in adipose tissue are used to treat patients, including patients with musculoskeletal diseases or disorders. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of regenerative cells obtained from the adipose tissue to a patient. The methods may be practiced in a closed system so that the stem cells are not exposed to an external environment prior to being administered to a patient. Accordingly, in a preferred method, regenerative cells present in adipose tissue are placed directly into a recipient along with such additives necessary to promote, engender or support a therapeutic musculoskeletal benefit.
1. A method for promoting restoration of an intervertebral disc in a subject comprising:
identifying a subject in need of intervertebral disc restoration;
obtaining a unit of adipose tissue from said subject;
processing said unit of adipose tissue obtained from said subject by separating adipose-derived cells comprising stem and progenitor cells from mature adipocytes and connective tissue, and washing, separating and concentration said adipose-derived cells to obtain a concentrated population of cells that comprises stem cells and endothelial progenitor cells; and
administering said concentrated population of cells to the intervertebral disc of said subject without culturing the concentrated population of cells prior to administration to the subject.
2. The method of claim 1 , wherein the concentrated population of cells further comprises a hydrogel liquid.
3. The method of claim 1 , wherein said concentrated population of cells is administered by direct injection into the intervertebral disc.
4. The method of claim 2 , wherein said concentrated population of cells is administered by injection into a gel that is placed within said subject.
5. The method of claim 1 , wherein said subject is identified as being in need of an intervertebral body spinal fusion.
6. The method of claim 1 , wherein said subject is identified as being in need of an intertransverse process spinal fusion.
7. The method of claim 1 , wherein one or more additives are added to the concentrated population of cells.
8. The method of claim 7 , wherein the one or more additives are growth factors, re-suspension fluids, cells, tissue, or tissue fragments or combinations thereof.
9. The method of claim 1 , wherein the concentrated population of cells are placed in a gel.
10. The method of claim 1 , wherein the administration comprises injecting the concentrated population of cells into the nucleus pulposis.
11. The method of claim 1 , wherein the concentrated population of cells is combined with a biocompatible matrix.
12. The method of claim 11 , wherein the biocompatible matrix is a resorbable scaffold.
13. The method of claim 1 , wherein the subject has degenerative disc disease.
14. The method of claim 1 , wherein the intervertebral disc is ruptured.
15. The method of claim 1 , wherein the subject has chronic inflammation of the intervertebral disc.
16. The method of claim 1 , wherein the intervertebral disc comprises a localized disc herniation with a contained or escaped extrusion.
17. The method of claim 1 , wherein the concentrated population of adipose-derived cells is cryopreserved.